AtriCure, Inc. v. Meng

CourtDistrict Court, S.D. Ohio
DecidedOctober 8, 2019
Docket1:19-cv-00054
StatusUnknown

This text of AtriCure, Inc. v. Meng (AtriCure, Inc. v. Meng) is published on Counsel Stack Legal Research, covering District Court, S.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
AtriCure, Inc. v. Meng, (S.D. Ohio 2019).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF OHIO WESTERN DIVISION

AtriCure, Inc.,

Plaintiff, Case No. 1:19-cv-00054

v. Judge Michael R. Barrett

Dr. Jian Meng, et al.,

Defendants.

OPINION & ORDER

This matter is before the Court upon Defendants’—Dr. Jian Meng (“Meng”) and Beijing Medical Scientific Co. Ltd (“Med-Zenith”)—Motion to Dismiss for Lack of Personal Jurisdiction or, Alternatively, Under Forum Non Conveniens.1 (Docs. 21, 22). AtriCure has filed a Response (Doc. 32) and Defendants filed a Reply (Doc. 33). I. BACKGROUND2 Plaintiff AtriCure is an Ohio-based medical device company that develops and sells surgical ablation systems used for the treatment of atrial fibrillation. (Doc. 1, ¶ 1). Defendant Meng is a citizen of the People’s Republic of China and resides in Beijing. (Doc. 1, ¶ 8). Meng is the Founder of ZenoMed, a Chinese company that distributes

1 Although Defendants request oral argument in the caption of their Motion, they do not state the grounds for that request. (Doc. 22); see S.D. Ohio Civ. R. 7.1(b)(2). Oral argument is not essential to the fair resolution of this matter and Defendants’ request is DENIED. See id.

2 The facts are construed in the light most favorable to AtriCure, the non-moving party. See Neogen Corp. v. Neo Gen Screening, Inc., 282 F.3d 883, 887 (6th Cir. 2002). The Court will not weigh the disputed facts, although it may consider Defendants' undisputed factual assertions. See Conn v. Zakharov, 667 F.3d 705, 711 (6th Cir. 2012). “This refusal to weigh [defendants'] controverting assertions is necessary to prevent non-resident defendants from avoiding jurisdiction simply by filing an affidavit that denies all jurisdictional facts.” Bracken v. DASCO Home Med. Equip., Inc., 954 F. Supp. 2d 686, 691 (S.D. Ohio 2013) (citing CompuServe, Inc. v. Patterson, 89 F.3d 1257, 1262 (6th Cir. 1996)). cardiovascular devices, and President of Defendant Med-Zenith. (Doc. 22 at PageID 177- 78); (Doc. 32-1, Exhibit A, ¶ 6). Defendant Dr. Guanglu Bai (“Bai”)3 is a Chinese citizen residing in Beijing and the former Director of Research and Development of non- defendant ZenoMed. (Doc. 1, ¶¶ 4, 8). Med-Zenith is a Chinese company, with its

principal office in Beijing, which develops, manufactures, and sells medical equipment. (Doc. 1, ¶ 10); (Doc. 22 at PageID 177). In 2005, Meng contacted AtriCure to develop a partnership wherein Meng would, through one of his entities, secure certain distribution and marketing rights for AtriCure’s medical devices in China and serve as AtriCure’s exclusive distributor in China. (Doc. 32- 1, Exhibit A, ¶ 31); see (Doc. 32-1, Exhibit 7, PageID 359-79 (“Exclusive Distribution Agreement for AtriCure, Inc. Products”). “From 2005 to 2017, ZenoMed and AtriCure entered into a series of agreements regarding ZenoMed’s acting as a distributor for AtriCure products in” China. (Doc. 22 at PageID 178) (citing (Doc. 22-1, ¶ 10)). For example, AtriCure and ZenoMed entered into a 2016 Distribution Agreement, in which

ZenoMed was to secure regulatory approvals in China for AtriCure’s medical products and act as exclusive distributor for certain AtriCure products in China. (Doc. 1, ¶¶2, 20- 23); (Doc. 1-2). Meng visited AtriCure’s Ohio facilities twice, each time for one day, to discuss training and marketing for the distribution of AtriCure’s products in China. (Doc. 22-1, ¶ 11). Meng and his related entities have engaged in numerous telecommunications and emails with AtriCure’s Ohio employees. (Doc. 32-1, Exhibit A, ¶ 35). Meng was the main

3 Bai has not been served as of the date of this Order. negotiator and contact point on the business relationship between Meng, his entities, and AtriCure. Id. AtriCure brings eight causes of action against the three Defendants: tortious interference, misappropriation of trade secrets, unfair competition, deceptive trade

practices, fraud, negligent misrepresentation, aiding and abetting, and civil conspiracy. (Doc. 1). AtriCure alleges that Meng and Bai used their roles as partners with AtiCure through ZenoMed—beginning over a decade before but including the 2016 Distribution Agreement—to acquire AtriCure’s confidential information and intellectual property. (Doc. 1, ¶ 39). AtriCure asserts that Meng and Bai subsequently provided that information to Med-Zenith, which is creating facially identical counterfeit versions of AtriCure’s products and seeking patent approval and licensing to compete with AtriCure in China. (Doc. 1, ¶¶ 38-40). II. PERSONAL JURISDICTION

Federal Rule of Civil Procedure 12(b)(2) provides that a defendant may seek dismissal if the court lacks personal jurisdiction over that defendant. “The party seeking to assert personal jurisdiction bears the burden of demonstrating that such jurisdiction exists.” Schneider v. Hardesty, 669 F.3d 693, 697 (6th Cir. 2012) (quoting Bird v. Parsons, 289 F.3d 865, 871 (6th Cir. 2002)). In the face of a supported motion to dismiss, the plaintiff may not rest on his pleadings, but must, by affidavit or otherwise, set forth specific evidence supporting jurisdiction. Theunissen v. Matthews, 935 F.2d 1454, 1458 (6th Cir. 1991) (citing Weller v. Cromwell Oil Co., 504 F.2d 927, 930 (6th Cir. 1974)). When a court considers a motion to dismiss pursuant to Rule 12(b)(2) without an evidentiary hearing, as here,4 the plaintiff’s burden is “relatively slight.” Air Prods. & Controls, Inc. v. Safetech Int'l, Inc., 503 F.3d 544, 549 (6th Cir. 2007) (quoting Am. Greetings Corp. v. Cohn, 839 F.2d 1164, 1169 (6th Cir. 1988)). Likewise, when a court

considers a motion to dismiss pursuant to Rule 12(b)(2) without an evidentiary hearing, the plaintiff “‘need only make a prima facie showing of jurisdiction.’” Bird, 289 F.3d at 871 (quoting Neogen, 282 F.3d at 887) (internal citation omitted). A plaintiff can make prima facie showing of personal jurisdiction by “establishing with reasonable particularity sufficient contacts between [the defendants] and the forum state to support jurisdiction.” Neogen, 282 F.3d at 887 (citing Provident Nat’l Bank v. Cal. Fed. Sav. & Loan Ass’n, 819 F.2d 434, 437 (3d Cir. 1987)). “To determine whether personal jurisdiction exists over a defendant, federal courts apply the law of the forum state.” CompuServe, 89 F.3d at 1262. “Under Ohio law, personal jurisdiction over non-resident defendants is available only if (1) the long-arm

statute confers jurisdiction and (2) jurisdiction is proper under the Federal Due Process Clause.” Conn, 667 F.3d at 712 (citing Kauffman Racing Equip., L.L.C. v. Roberts, 126 Ohio St.3d 81, 930 N.E.2d 784, 790 (2010); Goldstein v. Christiansen, 70 Ohio St.3d 232, 638 N.E.2d 541, 543 (1994)).

4 Defendants requested oral argument. Defendants did not request jurisdictional discovery or an evidentiary hearing. Cf. Theunissen v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

International Shoe Co. v. Washington
326 U.S. 310 (Supreme Court, 1945)
Koster v. (American) Lumbermens Mutual Casualty Co.
330 U.S. 518 (Supreme Court, 1947)
Piper Aircraft Co. v. Reyno
454 U.S. 235 (Supreme Court, 1982)
Burger King Corp. v. Rudzewicz
471 U.S. 462 (Supreme Court, 1985)
DRFP L.L.C. v. Republica Bolivariana De Venezuela
622 F.3d 513 (Sixth Circuit, 2010)
Gerber v. Riordan
649 F.3d 514 (Sixth Circuit, 2011)
Henry J. Weller v. Cromwell Oil Company
504 F.2d 927 (Sixth Circuit, 1974)
American Greetings Corporation v. Gerald A. Cohn
839 F.2d 1164 (Sixth Circuit, 1988)
David Schneider v. Michael Hardesty
669 F.3d 693 (Sixth Circuit, 2012)
Neogen Corporation v. Neo Gen Screening, Inc.
282 F.3d 883 (Sixth Circuit, 2002)
Allen King v. Eric Taylor
694 F.3d 650 (Sixth Circuit, 2012)
Kevin Miller v. AXA Winterthur Insurance Co.
694 F.3d 675 (Sixth Circuit, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
AtriCure, Inc. v. Meng, Counsel Stack Legal Research, https://law.counselstack.com/opinion/atricure-inc-v-meng-ohsd-2019.